Joel Isaacson & Co., LLC Compugen LTD Transaction History
Joel Isaacson & Co., LLC
- $2.17 Billion
- Q1 2025
A detailed history of Joel Isaacson & Co., LLC transactions in Compugen LTD stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 12,000 shares of CGEN stock, worth $21,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,000
Previous 22,000
45.45%
Holding current value
$21,360
Previous $33,000
48.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$5.15 Million1.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.4MShares$2.48 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.39MShares$2.47 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.05MShares$1.87 Million0.94% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.82 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $154M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...